Main
>
ONCOLOGY (**)
>
Kidney Cancer>RCC>MET ***
>
Treatment
>
USA. B. IpilimuMAb+NivoluMAb***
>
(*) EU Approval Date: 2019. 01.14.
(*) EU Approval Date: 2019. 01.14.'s products
This section has no products